Pharmacodynamic Evaluation of Intranasal Nalmefene

Clinical trial NCT04828005 · COMPLETED

Trial details

NCT number: NCT04828005
Sponsor: Opiant Pharmaceuticals Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacodynamic

Start date: 2021-03-30
Primary completion: 2022-03-14
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.